Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2128258 | 0.89 | ALDH1A1 (0.49) | ALDH1A1PKMMMESLC1A2KMT2A | |
| SCHEMBL9258688 | 0.82 | ALDH1A1 (0.61) | ALDH1A1PKMSLC1A2KMT2AHDAC3 | |
| SCHEMBL4381247 | 0.82 | ALDH1A1 (0.49) | ALDH1A1PKMMMESLC1A2KMT2A | |
| SCHEMBL8583037 | 0.82 | ALDH1A1 (0.49) | ALDH1A1PKMMMESLC1A2KMT2A | |
| SCHEMBL3505155 | 0.79 | ALDH1A1 (0.58) | ALDH1A1PKMMMESLC1A2KMT2A | |
| Ethylene SCHEMBL29141463 | 0.78 | ALDH1A1 (0.53) | ALDH1A1PKMMMESLC1A2KMT2A | |
| Ethylene SCHEMBL8387032 | 0.78 | ALDH1A1 (0.53) | ALDH1A1PKMMMESLC1A2KMT2A | |
| SCHEMBL24300565 | 0.78 | ALDH1A1 (0.56) | ALDH1A1PKMMMESLC1A2KMT2A | |
| SCHEMBL2332165 | 0.78 | ALDH1A1 (0.56) | ALDH1A1PKMMMESLC1A2KMT2A | |
| SCHEMBL698898 | 0.78 | ALDH1A1 (0.56) | ALDH1A1PKMMMESLC1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6968 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146088-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4748862-A2 | HETERODIMERIC PROTEINS | Xencor, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3620473-B1 | NOVEL HETERODIMERIC PROTEINS | XENCOR INC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260137822-A1 | MULTIVALENT IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY | ABDERA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-3865514-B9 | BISPECIFIC ANTIBODY BINDING DLL3 AND CD3 | AMGEN RES MUNICH GMBH (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743495-A2 | ANTI-CTHRC1 T CELL ENGAGERS AND METHODS OF USING THE SAME | Phenomic AI (CA) | 2026-05-20 | — | — | EP | disclosed |
| US-20260132199-A1 | ANTIBODY CONSTRUCTS FOR DLL3 AND CD3 | AMGEN RES MUNICH GMBH (DE) | 2026-05-14 | — | — | US | disclosed |
| EP-4741424-A2 | FC VARIANTS WITH ALTERED BINDING TO FCRN | Xencor, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-3817770-B1 | ANTI-STEAP1 ANTIGEN-BINDING PROTEIN | AMGEN INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12617853-B2 | Low pH pharmaceutical composition comprising T cell engaging antibody constructs | Amgen Research (Munich), GmbH (DE) | 2026-05-05 | — | — | US | disclosed |
| WO-1991013352-A1 | COMPLEMENT COMPONENTS AND BINDING LIGANDS IN FERTILITY | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1991-09-05 | — | — | WO | disclosed |
| WO-1991008231-A1 | [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1991-06-13 | — | — | WO | disclosed |
| WO-1991001133-A1 | T CELL RECEPTOR PEPTIDES AS THERAPEUTICS FOR AUTOIMMUNE AND MALIGNANT DISEASE | VANDENBARK ARTHUR ALLEN (US) | 1991-02-07 | — | — | WO | disclosed |
| WO-1990013643-A2 | GLYCOPROTEIN HORMONE RECEPTOR MOLECULES | GENENTECH, INC. (US) | 1990-11-15 | — | — | WO | disclosed |
| WO-1990013649-A1 | PRODUCTION OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR AND DNA ENCODING SAME | GENENTECH, INC. (US) | 1990-11-15 | — | — | WO | disclosed |
| EP-0391088-A2 | Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy | CENTER FOR BLOOD RESEARCH LABORATORIES, INC. (US) | 1990-10-10 | — | — | EP | disclosed |
| WO-1990010453-A1 | USE OF INTERCELLULAR ADHESION MOLECULES, AND THEIR BINDING LIGANDS IN THE TREATMENT OF ASTHMA | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1990-09-20 | — | — | WO | disclosed |
| EP-0387701-A1 | Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma | Boehringer Ingelheim Pharmaceuticals Inc. (US) | 1990-09-19 | — | — | EP | disclosed |
| EP-0387668-A1 | Intercellular adhesion molecule - 2 and its binding ligands | CENTER FOR BLOOD RESEARCH LABORATORIES, INC. (US) | 1990-09-19 | — | — | EP | disclosed |
| EP-0345723-A2 | Diethylenetriamine pentaacetic acid derivatives | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1989-12-13 | — | — | EP | disclosed |